Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine, or ARM, is an international organization with multiple stakeholders that represent the gene therapy, cell therapy, and tissue engineering sectors. ARM was founded in 2009 and is headquartered in Washington, United States.

ARM acts as a global advocate for advanced therapy techniques, and supports research, development, investments, and commercialization of treatments and cures across the globe.In 2019 ARM announced a Cell & Gene Therapies State of the Industry briefing in conjunction with Biotech Showcase.

The company looks to assess all FDM, EMA, and related guidance relevant to cell and gene therapy, including guidance to related manufacturing, CMC, and related issues. They support policies that address industrialization and manufacturing hurdles that developers have. They also promote international convergence of key regulation and guidance to promote global product development by identifying specific areas of regulatory inconsistency among jurisdictions.

Overview of the Alliance for Regenerative Medicine